» Articles » PMID: 34190425

Nanoparticle and Biomolecule Surface Modification Synergistically Increases Neural Electrode Recording Yield and Minimizes Inflammatory Host Response

Overview
Date 2021 Jun 30
PMID 34190425
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Due to their ability to interface with neural tissues, neural electrodes are the key tool used for neurophysiological studies, electrochemical detection, brain computer interfacing, and countless neuromodulation therapies and diagnostic procedures. However, the long-term applications of neural electrodes are limited by the inflammatory host tissue response, decreasing detectable electrical signals, and insulating the device from the native environment. Surface modification methods are proposed to limit these detrimental responses but each has their own limitations. Here, a combinatorial approach is presented toward creating a stable interface between the electrode and host tissues. First, a thiolated nanoparticle (TNP) coating is utilized to increase the surface area and roughness. Next, the neural adhesion molecule L1 is immobilized to the nanoparticle modified substrate. In vitro, the combined nanotopographical and bioactive modifications (TNP+L1) elevate the bioactivity of L1, which is maintained for 28 d. In vivo, TNP+L1 modification improves the recording performance of the neural electrode arrays compared to TNP or L1 modification alone. Postmortem histology reveals greater neural cell density around the TNP+L1 coating while eliminating any inflammatory microglial encapsulation after 4 weeks. These results demonstrate that nanotopographical and bioactive modifications synergistically produce a seamless neural tissue interface for chronic neural implants.

Citing Articles

Manipulating immune activity of macrophages: a materials and mechanics perspective.

Clevenger A, Jha A, Moore E, Raghavan S Trends Biotechnol. 2024; 43(1):131-144.

PMID: 39155172 PMC: 11717646. DOI: 10.1016/j.tibtech.2024.07.009.


Improving Sensitivity and Longevity of In Vivo Glutamate Sensors with Electrodeposited NanoPt.

Robbins E, Wong B, Pwint M, Salavatian S, Mahajan A, Cui X ACS Appl Mater Interfaces. 2024; 16(31):40570-40580.

PMID: 39078097 PMC: 11310907. DOI: 10.1021/acsami.4c06692.


Remote coupling of electrical and mechanical cues by diurnal photothermal irradiation synergistically promotes bone regeneration.

Lei H, Sun J, Dai Z, Wo K, Zhang J, Wang Y J Nanobiotechnology. 2024; 22(1):410.

PMID: 38992774 PMC: 11238389. DOI: 10.1186/s12951-024-02671-6.


Tuning Surface Adhesion Using Grayscale Electron-beam Lithography.

Pradhan A, Thimons L, Lavrik N, Kravchenko I, Jacobs T Langmuir. 2024; 40(28):14257-14265.

PMID: 38949567 PMC: 11256748. DOI: 10.1021/acs.langmuir.4c00669.


Improving the Biocompatibility and Functionality of Neural Interface Devices with Silica Nanoparticles.

Shi D, Narayanan S, Woeppel K, Cui X Acc Chem Res. 2024; 57(12):1684-1695.

PMID: 38814586 PMC: 11191400. DOI: 10.1021/acs.accounts.4c00160.


References
1.
Castagnola E, Woeppel K, Golabchi A, McGuier M, Chodapaneedi N, Metro J . Electrochemical detection of exogenously administered melatonin in the brain. Analyst. 2020; 145(7):2612-2620. PMC: 7236429. DOI: 10.1039/d0an00051e. View

2.
Zhong Y, Bellamkonda R . Dexamethasone-coated neural probes elicit attenuated inflammatory response and neuronal loss compared to uncoated neural probes. Brain Res. 2007; 1148:15-27. PMC: 1950487. DOI: 10.1016/j.brainres.2007.02.024. View

3.
Golabchi A, Wu B, Li X, Carlisle D, Kozai T, Friedlander R . Melatonin improves quality and longevity of chronic neural recording. Biomaterials. 2018; 180:225-239. PMC: 6179369. DOI: 10.1016/j.biomaterials.2018.07.026. View

4.
Woeppel K, Zheng X, Schulte Z, Rosi N, Cui X . Nanoparticle Doped PEDOT for Enhanced Electrode Coatings and Drug Delivery. Adv Healthc Mater. 2019; 8(21):e1900622. PMC: 6842062. DOI: 10.1002/adhm.201900622. View

5.
Yamada Y, Ueshima H . Methods of electrophoretical application of estrogen to a single neuron of the brain under in vivo and in vitro conditions. Endocrinol Jpn. 1978; 25(4):397-401. DOI: 10.1507/endocrj1954.25.397. View